Philips CPAP Cancer Lawsuit News

The US Attorney General Is Concerned Phillips Is Failing To Deliver a Timely CPAP Solution

The AG criticized Phillips and the FDA for a lack of transparency he says puts patients' lives at risk.

Monday, October 11, 2021 - US Attorney General William Tong has told the Food and Drug Administration (FDA) to step up their oversight efforts and get Royal Phillips to expedite the repair and replacement of millions of Phillips Sleep Apnea devices. The CPAP and ventilator devices were subject to a voluntary recall by Philips Respironics on June 14, 2021. The AG insists that the replacements be made immediately so that sleep apnea sufferers can resume enjoying the benefits of having a safe and restful night's sleep. More than three million users of one brand or another of the Phillips CPAP devices have been without a solution to the health-damaging symptoms of sleep apnea, such as being awakened several times per night by loud snoring, choking, and even stopping breathing.

The US Attorney General is concerned that Phillips is failing to provide the service in replacing the defective machines they have promised. The AG warns consumers that Philips Respironics of the following complaints by consumers who were attempting to return or fix their CPAP device. "Unfortunately, the notification issued by Philips Respironics to patients never explained how the company will repair or replace the defective devices. Patients have reported that calls to the toll-free phone number provided do not connect callers with people knowledgeable about the recall, and requests for return phone calls are not fulfilled," the AG wrote. The FDA has been overseeing the Phillips recall and has approved a replacement plan, the details of which have not been made public. The AG feels that this, coupled with the lack of communication with CPAP users is leading to confusion and frustration on the part of the people who may have been injured by the device. Phillips CPAP users have reported several lung disorders including asthma, emphysema, and lung cancer. Many have hired a CPAP recall lawyer and filed suit.

Patients should comply with the Phillips CPAP recall even if they were not actively using the machine. More than half of all sleep apnea users discontinued using the machine after less than one year. They must check to ensure their machine is not subject to a recall before resuming using it. Philips Respironics has admitted that the defects of leaching carcinogenic particles, chemicals, and gasses directly into the machine's airway and into the patient's lungs are life-threatening and should be taken seriously. All owners of the Phillips CPAP devices should go to the company's website and register their machine as the first step in getting a replacement without regard to having been actively using the machine or not. According to the US Attorney General, "Particulates released from degrading PE-PUR foam into devices' air pathways and off-gassing of chemicals are toxic and potentially carcinogenic, presenting a serious and unacceptable risk to patients. It is important to note that individual registration of affected machines is the first step in the recall process."

More Recent Philips CPAP Cancer Lawsuit News:

Lawyers for CPAP Cancer Lawsuits

We will represent all persons in involved in a BiPAP or CPAP cancer lawsuit on a contingency basis, meaning there are never any legal fees unless we win compensation in your case. Anyone who developed cancer or another serious side effect as a result of using a Philips CPAP sleep apnea machine or ventilator in --or is a family member of such a person--is eligible to receive a free, no-obligation case review from our attorneys. Simply contact our firm through the online contact form or the chat feature and one of our Philips BiPAP cancer lawyers serving will contact you promptly to discuss your case.



Privacy Notice: This site uses cookies for advertising, analytics and to improve our site services. By continuing to use our site, you agree to our use of cookies. For more information, see our cookie and privacy policy.